This article outlines six overlooked reasons why full insourcing rarely supports long-term cost control, quality, or compliance, and why outsourcing to a trusted partner may, in fact, be the most responsible path forward.

At PharmAdvice, we review our business continuity plan (BCP) annually. But prompted by recent international events, we have given it a comprehensive re-evaluation to ensure it’s aligned with all relevant risks and threats.